These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9064900)

  • 1. [Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer].
    Bershteĭn LM; Poroshina TE; Tsyrlina EV; Gamaiunova VB; Kovalenko IG; Iurin AG; Evtushenko TP; Larionov AA; Zimarina TS; Ivanova OA; Semiglazov VF
    Vopr Onkol; 1996; 42(5):36-9. PubMed ID: 9064900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonal metabolic status in breast cancer patients after conservative surgery: comparison with known prognostic criteria].
    Tsyrlina EV; Gamaiunova VB; Poroshina TE; Kovalenko IG; Semiglazov VF; Berstein LM
    Vopr Onkol; 1999; 45(3):261-4. PubMed ID: 10443228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between tumor tissue aromatase, histological pattern and reproductive status in patients with breast cancer].
    Larionov AA; Uporov AV; Semiglazov VF; Berstein LM
    Vopr Onkol; 1998; 44(1):37-42. PubMed ID: 9578729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal-metabolic status of cancer patients with late-onset menopause].
    Bershteĭn DM; Chernobrovkina AE; Gamaiunova VB; Tsyrlina EV; Kvachevskaia IuO; Kovalenko IG
    Vopr Onkol; 2003; 49(2):152-5. PubMed ID: 12785194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid-binding protein levels in breast cancer patients].
    Bezrukavnikova NV; Kokhanov AV; Kriventsev IuA; Nikulina DM; Bershteĭn LM; Kutukov VV
    Vopr Onkol; 2007; 53(4):409-13. PubMed ID: 17969402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease.
    He H; Yang F; Liu X; Zeng X; Hu Q; Zhu Q; Tu B
    Menopause; 2007; 14(3 Pt 1):385-90. PubMed ID: 17108845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
    J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adipose and lean body mass in obese pre- and post-menopausal patients with breast cancer: the modifying role of smoking].
    Bershteĭn LM; Tsyrlina EV; Semiglazov VF; Larionov AA; Kovalenko IG; Ivanova OA
    Vopr Onkol; 1994; 40(7-12):302-9. PubMed ID: 7610625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women.
    Boyapati SM; Shu XO; Gao YT; Dai Q; Yu H; Cheng JR; Jin F; Zheng W
    Cancer Causes Control; 2004 Apr; 15(3):305-11. PubMed ID: 15090725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood insulin and insulin sensitivity in breast cancer patients of various ages: the effect of smoking].
    Tsyrlina EV; Gamaiunova VB; Kovalenko IG; Berstein LM
    Vopr Onkol; 1998; 44(1):43-8. PubMed ID: 9578730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.